Anti-ITGB4 was found to significantly inhibit adhesion of SKOV-3R248 and OVCAR-3 cells to Met5A cells, suggesting a role of integrin β4 in mutant p53-mediated ovarian cancer-mesothelial cell adhesion (Fig. 5C). Here, TP53 is linked to ovarian cancer.